This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer Logo
BAYERPROYour Resource Portal
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Women's Health
  • Jaydess® ▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Ophthalmology
  • Eylea® (aflibercept) 8mg
Products
  • Cardiology
  • Oncology
  • Ophthalmology
  • Women's Health
  • Cardiology Resources
  • Oncology Resources
  • Ophthalmology Resources
  • Women's Health Resources
  • Bayer Events & On Demand Webinars
  • Cardiology Events & On Demand Webinar
  • Oncology Events & On Demand Webinars
  • Ophthalmology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Cardiology Learning Zone
  • Oncology Learning Zone
  • Ophthalmology Learning Zone
  • Women's Health Learning Zone
  • Cardiology Podcasts
  • Oncology Podcasts
  • Ophthalmology Podcasts
closesearch
Recent Searches
    You are now leaving BayerPRO

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    BayerPRO IRE Above Brand Header

    Ophthalmology Events & On Demand Webinars

    View more
    EYLEA® (aflibercept) 8mg | Events & Webinars
    Discover Events & On Demand Webinars below that you can access to learn more about EYLEA 8mg.
    EYLEA Prescribing Information
    PP-EYL_8mg-IE-0161-1, January 2026

    Women's Health Events & On Demand Webinars

    View more
    Bayer's 18th Annual Lecture in Women's Health (2019)
    Urogynaecology in general practice – Pelvic organ collapse and other challenges
    PP-PF-WHC-IE-0911-1, February 2026
    Bayer's 21st Annual Lecture in Women's Health (2022)
    IUS and young women – Managing patient concerns and practical insertion tips
    PP-PF-WHC-IE-0914-1, February 2026
    Bayer's 19th Annual Lecture in Women's Health (2020)
    Polycystic ovarian syndrome – An overview and disease management | Sexual health – Problems and challenges in practice
    PP-PF-WHC-IE-0912-1, February 2026
    Bayer's 20th Annual Lecture in Women's Health (2021)
    GP Selfcare | Challenges in the field of Subfertility
    PP-PF-WHC-IE-0913-1, February 2026